A Pilot Study Assessing the Effectiveness of Use of Guided Imagery for Treatment of Pain and Symptom Management in Women With Post-mastectomy Pain Syndrome
Launched by M.D. ANDERSON CANCER CENTER · Jun 2, 2022
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
OBJECTIVES:
Primary objective:
-To evaluate the effectiveness of use of Guided imagery and deep breathing techniques in pain management compared to control arm in patients with post-mastectomy pain syndrome who don't receive intervention and only receive standard care.
Secondary objective:
To evaluate effectiveness of Guided imagery and deep breathing techniques in symptom cluster management including fatigue, sleep, depression, and anxiety and in general quality of life compared to control arm who don't receive intervention and only receive standard care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Breast Cancer patients who were performed mastectomy in previous 12 months
- • 2. Post-mastectomy pain syndrome \>4 weeks.
- • 3. Patients who report 2-10 on the baseline pain severity score or 2-10 on the baseline pain interference score
- • 4. Patients ≥ 18 years old and ≤ 70 years old
- • 5. Must understand and read English, sign a written informed consent, and follow protocol requirements
- • 6. If on medication for anxiety or depression, stable dose of medications for management of anxiety or depression symptoms for at least six weeks prior to enrollment with no plans to change medications in the subsequent four weeks. Increases or decreases allowed within drug class, but changing drug class will make patient in-evaluable
- Exclusion Criteria:
- • 1. Pending surgery during treatment
- • 2. Suicidal ideation
- • 3. Diagnosis of a formal thought disorder (e.g., schizophrenia)
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Uzondu Osuagwu, MD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials